期刊文献+

组织多普勒成像评价2型糖尿病患者左心室纵向收缩功能 被引量:5

Evaluation of left ventricular systolic function with tissue Doppler imaging in patients with type 2 diabetes
下载PDF
导出
摘要 目的探讨组织多普勒成像技术(TDI)对评价2型糖尿病患者左心室纵向收缩功能改变的临床应用价值。方法对42例2型糖尿病患者和25名健康志愿者行组织多普勒超声心动图检查,测量左心室各室壁基底段、中间段、心尖段共18个节段的心肌收缩期峰值运动速度(Sm)、位移值(Dm)及应变率(SRs)。结果两组糖尿病患者心肌收缩期最大位移和峰值应变率均较正常对照组有明显减低(P<0.01);合并高血压组左心室壁中间段心肌收缩期峰值运动速度也较对照组明显减低(P<0.05)。结论TDI技术为糖尿病心脏病变左心室收缩功能的早期检测提供了一种无创方法,局部心肌收缩期最大位移及峰值应变率能够成为检测糖尿病患者左心室收缩功能变化较敏感指标。 Objective To evaluate the clinical application of the tissue Doppler imaging (TDI) in investigating the cardiac longitudinal systolic function in the patients with type 2 diabetes mellitus. Methods Forty-two patients with type 2 diabetes mellitus and 25 volunteers underwent TDI. The long axis myocardial peak systolic velocity (Sm), displacement (Dm) and strain rates (SRs) of 18 segments in different left ventricular walls were measured. Results The Dm and SRs of left ventricular wall in diabetic group dramatically decreased (P〈0.01). Meanwhile, the diabetic combined hypertension group had much lower Sm of ventricular middle segments than the control group (P〈0. 05). Conclusion The stain rate and tissue tracking are sensitive and reliable to evaluate the early local cardiac systolic function in the patients with diabetes mellitus. TDI can be used as an noninvasive method to detect early systolic dysfunction.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第10期1781-1784,共4页 Chinese Journal of Medical Imaging Technology
基金 陕西省自然科学基金(2006C2-46)
关键词 糖尿病 组织多普勒成像 定量组织速度 组织追踪 应变率 Diabetes mellitus Tissue Doppler imaging Quantitative tissues velocity Tissues tracking Strain rate
  • 相关文献

参考文献11

  • 1Hayat SA, Patel B, Khattar RS, et al. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci, 2004, 107(6) :539- 557.
  • 2American Diabetes Association I, Inc. Diagnosis and Classification of Diabetes Mellitus Clinical Practice Recommendations Diabetes Care, 2004,27(Suppl 1) :5-10.
  • 3Phillips B. The JNC 7 hypertension guidelines, JAMA, 2003,290 (10) : 1312-1315.
  • 4Karnafel W. Diabetic cardiomyopathy. Pathos-physiology and clinical implications. Przegl Lek, 2000,57(Suppl 4) : 9-11.
  • 5Emilsson K, Wandt B. The relation between mitral annulus motion and ejection fraction changes with age and heart size. Clin Physiol, 2000,20 ( 1 ) : 38-43.
  • 6Sengupta PP, Mohan JC, Pandian NG, et al. Tissue Doppler echocardiography, prineiples and applications. Indian Heart J, 2002, 54(4) :368-378.
  • 7Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation, 2000, 101(19) :2271-2276.
  • 8Kajstura J, Fiordaliso F, Andredi AM. IGF21 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin Ⅱ-mediated oxidative stress. Diabetes, 2001,50(2) : 1414-1424.
  • 9Kawaguchi M, Hay I, Fetics B, et al. Combined ventricular sys tollc and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation, 2003, 107(5):714-720.
  • 10Choi KM, Zhong Y, Hoit BD, et al. Defective intracellular Ca^2+ signaling contributes to cardiomyopathy in typel diabetic rats. Am J Physical Heart Cire Physical, 2002,283(4) : H1398-1408.

同被引文献30

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部